# Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis

> **NCT02239666** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 899 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **OTHER:** NIS

## Key facts

- **NCT ID:** NCT02239666
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-01
- **Primary completion:** 2017-01-05
- **Final completion:** 2017-01-05
- **Target enrollment:** 899 (ACTUAL)
- **Last updated:** 2017-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02239666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02239666, "Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02239666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*